Research

Items by Masuyer, Geoffrey

Up a level
Export as [feed] RSS 1.0 [feed] Atom [feed] RSS 2.0
Group by: Item Type | Date | No Grouping
Jump to: Articles | Thesis
Number of items: 23.

Articles

Larmuth, K. M., Masuyer, G., Douglas, R. G., Schwager, S. L., Acharya, K. R. and Sturrock, E. D., 2016. Kinetic and structural characterisation of amyloid-β peptides hydrolysis by human angiotensin-1-converting enzyme. FEBS Journal, 283 (6), pp. 1060-1076.

Masuyer, G., Douglas, R. G., Sturrock, E. D. and Acharya, K. R., 2015. Structural basis of Ac-SDKP hydrolysis by Angiotensin-I converting enzyme. Scientific Reports, 5, 13742.

Kramer, G. J., Mohd, A., Schwager, S. L. U., Masuyer, G., Acharya, K. R., Sturrock, E. D. and Bachmann, B. O., 2014. Interkingdom pharmacology of angiotensin-I converting enzyme inhibitor phosphonates produced by actinomycetes. ACS Medicinal Chemistry Letters, 5 (4), pp. 346-351.

Michaud, A., Acharya, K. R., Masuyer, G., Quenech'du, N., Gribouval, O., Morinière, V., Gubler, M.-C. and Corvol, P., 2014. Absence of cell surface expression of human ACE leads to perinatal death. Human Molecular Genetics, 23 (6), pp. 1479-1491.

Douglas, R. G., Sharma, R. K., Masuyer, G., Lubbe, L., Zamora, I., Acharya, K. R., Chibale, K. and Sturrock, E. D., 2014. Fragment-based design for the development of N-domain-selective angiotensin-1-converting enzyme inhibitors. Clinical Science, 126 (4), pp. 305-313.

Masuyer, G., Mohd, A., Czarny, B., Beau, F., Schwager, S. L. U., Sturrock, E. D., Isaac, R. E., Dive, V. and Acharya, K. R., 2014. Crystal structures of highly specific phosphinic tripeptide enantiomers in complex with the angiotensin-I converting enzyme. FEBS Journal, 281 (3), pp. 943-956.

Yates, C. J., Masuyer, G., Schwager, S. L. U., Mohd, A., Sturrock, E. D. and Acharya, K. R., 2014. Molecular and thermodynamic mechanisms of the chloride-dependent human angiotensin-I-converting enzyme (ACE). Journal of Biological Chemistry, 289 (3), pp. 1798-1814.

Masuyer, G., Chaddock, J. A., Foster, K. A. and Ravi Acharya, K., 2014. Engineered botulinum neurotoxins as new therapeutics. Annual Review of Pharmacology and Toxicology, 54, pp. 27-51.

Akif, M., Masuyer, G., Bingham, R. J., Sturrock, E. D., Isaac, R. E. and Acharya, K. R., 2012. Structural basis of peptide recognition by the angiotensin-1 converting enzyme homologue AnCE from Drosophila melanogaster. FEBS Journal, 279 (24), pp. 4525-4534.

Stancombe, P. R., Masuyer, G., Birch-Machin, I., Beard, M., Foster, K. A., Chaddock, J. A. and Acharya, K. R., 2012. Engineering botulinum neurotoxin domains for activation by toxin light chain. FEBS Journal, 279 (3), pp. 515-523.

Masuyer, G., Jabeen, T., Oberg, C. T., Leffler, H., Nilsson, U. J. and Acharya, K. R., 2012. Inhibition mechanism of human galectin-7 by a novel galactose-benzylphosphate inhibitor. FEBS Journal, 279 (2), pp. 193-202.

Anthony, C. S., Masuyer, G., Sturrock, E. D. and Acharya, K. R., 2012. Structure based drug design of angiotensin-i converting enzyme inhibitors. Current Medicinal Chemistry, 19 (6), pp. 845-855.

Masuyer, G., Stancombe, P., Chaddock, J. A. and Acharya, K. R., 2011. Structures of engineered Clostridium botulinum neurotoxin derivatives. Acta Crystallographica Section F-Structural Biology and Crystallization Communications, 67 (12), pp. 1466-1472.

Akif, M., Masuyer, G., Schwager, S. L. U., Bhuyan, B. J., Mugesh, G., Isaac, R. E., Sturrock, E. D. and Acharya, K. R., 2011. Structural characterization of angiotensin I-converting enzyme in complex with a selenium analogue of captopril. FEBS Journal, 278 (19), pp. 3644-3650.

Masuyer, G., Beard, M., Cadd, V. A., Chaddock, J. A. and Acharya, K. R., 2011. Structure and activity of a functional derivative of Clostridium botulinum neurotoxin B. Journal of Structural Biology, 174 (1), pp. 52-57.

Rouget, C., Quinton, L., Maiga, A., Gales, C., Masuyer, G., Malosse, C., Chamot-Rooke, J., Thai, R., Mourier, G., de Pauw, E., Gilles, N. and Servent, D., 2010. Identification of a novel snake peptide toxin displaying high affinity and antagonist behaviour for the alpha(2)-adrenoceptors. British Journal of Pharmacology, 161 (6), pp. 1361-1374.

Quinton, L., Girard, E., Maiga, A., Rekik, M., Lluel, P., Masuyer, G., Larregola, M., Marquer, C., Ciolek, J., Magnin, T., Wagner, R., Molgo, J., Thai, R., Fruchart-Gaillard, C., Mourier, G., Chamot-Rooke, J., Menez, A., Palea, S., Servent, D. and Gilles, N., 2010. Isolation and pharmacological characterization of AdTx1, a natural peptide displaying specific insurmountable antagonism of the alpha(1A)-adrenoceptor. British Journal of Pharmacology, 159 (2), pp. 316-325.

Masuyer, G., Thiyagarajan, N., James, P. L., Marks, P. M. H., Chaddock, J. A. and Acharya, K. R., 2009. Crystal structure of a catalytically active, non-toxic endopeptidase derivative of Clostridium botulinum toxin A. Biochemical and Biophysical Research Communications, 381 (1), pp. 50-53.

Thesis

Masuyer, G., 2012. Structure and activity of Clostridium botulinum neurotoxin functional fragments. Thesis (Doctor of Philosophy (PhD)). University of Bath.

This list was generated on Tue Aug 15 17:21:05 2017 IST.